Literature DB >> 12413934

Chemotherapy for advanced epithelial ovarian carcinoma.

Nelson Gustavo Neder Kalil1, William Patrick McGuire.   

Abstract

Advanced epithelial ovarian cancer (AOC) is the most common clinical presentation of ovarian cancer. Virtually all patients will require some form of chemotherapy with curative or palliative intent. Prognostic factors, first- and second-line therapy, as well as experimental approaches for AOC are reviewed.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12413934     DOI： 10.1053/beog.2002.0307

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN： 1521-6934            Impact factor:   5.237


  4 in total

1.  Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule.

Authors:  Sangiliyandi Gurunathan; Jae Woong Han; Eun Su Kim; Jung Hyun Park; Jin-Hoi Kim
Journal:  Int J Nanomedicine       Date:  2015-04-15

Review 2.  Ovarian damage from chemotherapy and current approaches to its protection.

Authors:  N Spears; F Lopes; A Stefansdottir; V Rossi; M De Felici; R A Anderson; F G Klinger
Journal:  Hum Reprod Update       Date:  2019-11-05       Impact factor: 15.610

3.  Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling.

Authors:  A D Santin; F Zhan; S Bellone; M Palmieri; S Cane; M Gokden; J J Roman; T J O'Brien; E Tian; M J Cannon; J Shaughnessy; S Pecorelli
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

4.  Chemotherapy drug response in ovarian cancer cells strictly depends on a cathepsin D-Bax activation loop.

Authors:  Roberta Castino; Claudia Peracchio; Alessandra Salini; Giuseppina Nicotra; Nicol F Trincheri; Marina Démoz; Guido Valente; Ciro Isidoro
Journal:  J Cell Mol Med       Date:  2008-07-24       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.